Reports
Reports
Sale
North America biobanking market size was valued at USD 1.1 billion in 2023, driven by the rising prevalence of chronic diseases and the growing demand for effective treatments in the region. The market is expected to grow at a CAGR of 6.31% during the forecast period of 2024-2032, with the values likely to rise from USD 1.2 billion in 2024 to USD 2 billion by 2032.
Biobank is a type of biorepository containing large collections of biological materials (usually human). The large-scale biomedical database acts as a research resource to facilitate new scientific discoveries. Biological samples in biobanks can act as a vital tool for medical research and accelerate the development of new and innovative treatments.
North America biobanking market growth is driven by the rising prevalence of chronic diseases, such as cancer, cardiovascular diseases, and diabetes, in the region. According to the Centers for Disease Control and Prevention, 6 out of 10 Americans are affected by at least one chronic disease. Moreover, chronic diseases not only rank as the leading causes of death and disability in America but are also a major driver of healthcare costs. Biobanks help in studying the genetic and environmental factors resulting in chronic diseases. Thus, with the growing prevalence of chronic diseases, the demand for biological samples in biomedical research is expected to rise, which will boost the market growth.
Technological advancements such as the development of computational tools to analyze huge volumes of complex data in biobanks are expected to boost the North America biobanking market demand in the forecast period. In December 2023, a study primarily funded by the National Institute of Aging (a division of the United States National Institutes of Health) revealed the development of a suite of free computational tools that can analyze brain dissection photographs from brain biobanks and reconstruct a three-dimensional picture of the brain, which can help to understand neurodegenerative diseases and find their potential treatments. Thus, data from biobanks is increasingly used to advance the understanding of various brain disorders, which are anticipated to propel the market demand.
North America biobanking market share is likely to be positively impacted by increased fundings from government organizations to improve biobanking infrastructure and support research initiatives. In December 2023, New York-based Wilmot Cancer Institute (leader in cancer care and research) received a grant worth USD 339k from Empire State Development (New York State funds). The funding will help in renovations and the establishment of new technology for the institute’s Biobank Shared Resource. Such investments will support biobank upgrades and are likely to augment market size in the region.
The report offers a detailed analysis of the market based on the following segments:
Market Breakup | Categories |
Equipment | Cryogenic Storage Systems, Alarm Monitoring Systems, Others |
Media | Optimized Media, Non-Optimized Media, Others |
Services | Human Tissue Biobanking, Stem Cell Biobanking, Cord Banking, DNA/RNA Biobanking, Others |
Biospecimen Type | Human Tissues, Human Organs, Stem Cells, Others |
Application | Drug Discovery, Disease Research, Others |
End User | Hospitals, Cosmetology Clinics, Ambulatory Surgical Centers, Others |
Countries | United States of America, Canada |
The key features of the market report include patent analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Equipment |
|
Breakup by Media |
|
Breakup by Services |
|
Breakup by Biospecimen Type |
|
Breakup by Application |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Supplier Landscape |
|
Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 North America Biobanking Market Overview
3.1 North America Biobanking Market Historical Value (2017-2023)
3.2 North America Biobanking Market Forecast Value (2024-2032)
4 North America Biobanking Market Landscape*
4.1 North America Biobanking: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 North America Biobanking: Product Landscape
4.2.1 Analysis by Equipment
4.2.2 Analysis by Service
5 North America Biobanking Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter’s Five Forces Analysis
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 North America Biobanking Market Segmentation (2017-2032)
6.1 North America Biobanking Market (2017-2032) by Equipment
6.1.1 Market Overview
6.1.2 Cryogenic Storage Systems
6.1.3 Alarm Monitoring Systems
6.1.4 Others
6.2 North America Biobanking Market (2017-2032) by Media
6.2.1 Market Overview
6.2.2 Optimized Media
6.2.3 Non-Optimized Media
6.2.4 Others
6.3 North America Biobanking Market (2017-2032) by Services
6.3.1 Market Overview
6.3.2 Human Tissue Biobanking
6.3.3 Stem Cell Biobanking
6.3.4 Cord Banking
6.3.5 DNA/RNA Biobanking
6.3.6 Others
6.4 North America Biobanking Market (2017-2032) by Biospecimen Type
6.4.1 Market Overview
6.4.2 Human Tissues
6.4.3 Human Organs
6.4.4 Stem Cells
6.4.5 Others
6.5 North America Biobanking Market (2017-2032) by Application
6.5.1 Market Overview
6.5.2 Drug Discovery
6.5.3 Disease Research
6.5.4 Others
6.6 North America Biobanking Market (2017-2032) by End User
6.6.1 Market Overview
6.6.2 Hospitals
6.6.3 Cosmetology Clinics
6.6.4 Ambulatory Surgical Centers
6.6.5 Others
6.7 North America Biobanking Market (2017-2032) by Countries
6.7.1 Market Overview
6.7.2 United States of America
6.7.3 Canada
7 United States of America Biobanking Market (2017-2032)
7.1 United State of America Biobanking Market (2017-2032) by Equipment
7.1.1 Market Overview
7.1.2 Cryogenic Storage Systems
7.1.3 Alarm Monitoring Systems
7.1.4 Others
7.2 United State of America Biobanking Market (2017-2032) by Media
7.2.1 Market Overview
7.2.2 Optimized Media
7.2.3 Non-Optimized Media
7.2.4 Others
7.3 United state of America Biobanking Market (2017-2032) by Services
7.3.1 Market Overview
7.3.2 Human Tissue Biobanking
7.3.3 Stem Cell Biobanking
7.3.4 Cord Banking
7.3.5 DNA/RNA Biobanking
7.3.6 Others
7.4 United State of America Biobanking Market (2017-2032) by Biospecimen Type
7.4.1 Market Overview
7.4.2 Human Tissues
7.4.3 Human Organs
7.4.4 Stem Cells
7.4.5 Others
7.5 United State of America Biobanking Market (2017-2032) by Application
7.5.1 Market Overview
7.5.2 Drug Discovery
7.5.3 Disease Research
7.5.4 Others
7.6 United State of America Biobanking Market (2017-2032) by End User
7.6.1 Market Overview
7.6.2 Hospitals
7.6.3 Cosmetology Clinics
7.6.4 Ambulatory Surgical Centers
7.6.5 Others
8 Canada Biobanking Market (2017-2032)
8.1 Canada Biobanking Market (2017-2032) by Equipment
8.1.1 Market Overview
8.1.2 Cryogenic Storage Systems
8.1.3 Alarm Monitoring Systems
8.1.4 Others
8.2 Canada Biobanking Market (2017-2032) by Media
8.2.1 Market Overview
8.2.2 Optimized Media
8.2.3 Non-Optimized Media
8.2.4 Others
8.3 Canada Biobanking Market (2017-2032) by Services
8.3.1 Market Overview
8.3.2 Human Tissue Biobanking
8.3.3 Stem Cell Biobanking
8.3.4 Cord Banking
8.3.5 DNA/RNA Biobanking
8.3.6 Others
8.4 Canada Biobanking Market (2017-2032) by Biospecimen Type
8.4.1 Market Overview
8.4.2 Human Tissues
8.4.3 Human Organs
8.4.4 Stem Cells
8.4.5 Others
8.5 Canada Biobanking Market (2017-2032) by Application
8.5.1 Market Overview
8.5.2 Drug Discovery
8.5.3 Disease Research
8.5.4 Others
8.6 Canada Biobanking Market (2017-2032) by End User
8.6.1 Market Overview
8.6.2 Hospitals
8.6.3 Cosmetology Clinics
8.6.4 Ambulatory Surgical Centers
8.6.5 Others
9 Regulatory Framework
10 Patent Analysis
10.1 Analysis by Type of Patent
10.2 Analysis by Publication year
10.3 Analysis by Issuing Authority
10.4 Analysis by Patent Age
10.5 Analysis by CPC Analysis
10.6 Analysis by Patent Valuation
10.7 Analysis by Key Players
11 Funding and Investment Analysis
11.1 Analysis by Funding Instances
11.2 Analysis by Type of Funding
11.3 Analysis by Funding Amount
11.4 Analysis by Leading Players
11.5 Analysis by Leading Investors
11.6 Analysis by Geography
12 Partnership and Collaborations Analysis
12.1 Analysis by Partnership Instances
12.2 Analysis by Type of Partnership
12.3 Analysis by Leading Players
12.4 Analysis by Geography
13 Supplier Landscape
13.1 Market Share by Top 5 Companies
13.2 Atlanta Biologicals Inc. (Bio-Techne Corporation)
13.2.1 Financial Analysis
13.2.2 Product Portfolio
13.2.3 Demographic Reach and Achievements
13.2.4 Mergers and Acquisitions
13.2.5 Certifications
13.3 Becton, Dickinson and Company
13.3.1 Financial Analysis
13.3.2 Product Portfolio
13.3.3 Demographic Reach and Achievements
13.3.4 Mergers and Acquisitions
13.3.5 Certifications
13.4 BioLifeSolution Inc.
13.4.1 Financial Analysis
13.4.2 Product Portfolio
13.4.3 Demographic Reach and Achievements
13.4.4 Mergers and Acquisitions
13.4.5 Certifications
13.5 Chart Industries Inc.
13.5.1 Financial Analysis
13.5.2 Product Portfolio
13.5.3 Demographic Reach and Achievements
13.5.4 Mergers and Acquisitions
13.5.5 Certifications
13.6 Hamilton Company
13.6.1 Financial Analysis
13.6.2 Product Portfolio
13.6.3 Demographic Reach and Achievements
13.6.4 Mergers and Acquisitions
13.6.5 Certifications
13.7 Qiagen NV
13.7.1 Financial Analysis
13.7.2 Product Portfolio
13.7.3 Demographic Reach and Achievements
13.7.4 Mergers and Acquisitions
13.7.5 Certifications
13.8 Sigma-Aldrich Inc. (Merck KGaA)
13.8.1 Financial Analysis
13.8.2 Product Portfolio
13.8.3 Demographic Reach and Achievements
13.8.4 Mergers and Acquisitions
13.8.5 Certifications
13.9 STEMCELL Technologies Inc.
13.9.1 Financial Analysis
13.9.2 Product Portfolio
13.9.3 Demographic Reach and Achievements
13.9.4 Mergers and Acquisitions
13.9.5 Certifications
13.10 Thermo Fisher Scientific Inc.
13.10.1 Financial Analysis
13.10.2 Product Portfolio
13.10.3 Demographic Reach and Achievements
13.10.4 Mergers and Acquisitions
13.10.5 Certifications
13.11 VWR International LLC
13.11.1 Financial Analysis
13.11.2 Product Portfolio
13.11.3 Demographic Reach and Achievements
13.11.4 Mergers and Acquisitions
13.11.5 Certifications
14 North America Biobanking Market – Distribution Model (Additional Insight)
14.1 Overview
14.2 Potential Distributors
14.3 Key Parameters for Distribution Partner Assessment
15 Key Opinion Leaders (KOL) Insights (Additional Insight)
16 Company Competitiveness Analysis (Additional Insight)
16.1 Very Small Companies
16.2 Small Companies
16.3 Mid-Sized Companies
16.4 Large Companies
16.5 Very Large Companies
17 Payment Methods (Additional Insight)
17.1 Government Funded
17.2 Private Insurance
17.3 Out-of-Pocketn
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
The market attained a value of about USD 1.1 billion in 2023 driven by the rising prevalence of chronic diseases and the growing demand for effective treatments in the region.
The market is anticipated to grow at a CAGR of 6.31% during the forecast period of 2024-2032, likely to reach a market value of USD 2 billion by 2032.
The growing demand for precision medicine and the rising funding from the government are fuelling the demand for the market.
One of the significant trends in the market is technological advancements such as the development of computational tools to analyze huge volumes of complex data in biobanks. In December 2023, researchers developed a suite of computational tools that can reconstruct a three-dimensional picture of the brain from brain biobanks, which can help advance the understanding of neurodegenerative diseases.
Based on the equipment, the market is segmented into cryogenic storage systems, and alarm monitoring systems, among others.
Services available in the market include human tissue biobanking, stem cell biobanking, cord banking, and DNA/RNA biobanking, among others.
By biospecimen type, the market is divided into human tissues, human organs, and stem cells, among others.
The market breakup by media includes optimized media and non-optimized media, among others.
End users of the market are hospitals, cosmetology clinics, and ambulatory surgical centers, among others.
Major application areas of biobanking include drug discovery and disease research, among others.
The market segmentation by countries includes the United States of America and Canada.
The key players in the market are Atlanta Biologicals Inc. (Bio-Techne Corporation), Becton, Dickinson and Company, BioLifeSolution Inc., Chart Industries Inc., Hamilton Company, Qiagen NV, Sigma-Aldrich Inc. (Merck KGaA), STEMCELL Technologies Inc., Thermo Fisher Scientific Inc., and VWR International LLC.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.